What This Means for You How the Weight-Loss Pathway Opened Up From Announcement to Live Program On November 6, 2025 , the Trump administration announced agreements with Eli Lilly and Novo Nordisk to expand Medicare coverage of GLP-1 medications (a class of weight loss and diabetes drugs including Wegovy, Ozempic, and Zepbound) for obesity
However, Saxenda is currently out of stock, but generic liraglutide or Nevolat is available as an alternative
Confidential Private Service Comfortable, nonjudgemental consultations No GP Referral Required Immediate access to treatment Expert Pharmacists Qualified to assess and prescribe Integrated Care Easy links to Blood Pressure Check, Cholesterol Testing, Diabetes Screening Transparent Pricing Clear costs with no hidden fees Google Reviews NHS & Private Treatments FAQs Is a B12 injection better than tablets
Saxenda is a GLP-1 receptor agonist used for weight management via daily subcutaneous injection in the abdomen, thigh, or upper arm
However, highest available dose does not mean optimal dose for every patient
The Gila monster peptide worked similarly in humans but lasted much longer in the bloodstream, making it a viable therapeutic tool